Most countries in South Asia have developed essential drug lists to determine what drugs governments should purchase. Yet if countries were able to decide on a common essential drug list and to have a commonly agreed-on set of regulations, their procurement units could negotiate with drug companies collectively instead of individually, strengthening their bargaining position and securing lower prices.
Countries should therefore compare their lists and rationalize them, to eliminate country differences. International cooperation may well result in lower prices in those